Afficher la couverture '[Tamoxifen in the adjuvant setting for breast cancer: Reflexions about the risk of uterine carcinosarcoma] | Leung, F.' en grand format
/5

0 avis

[Tamoxifen in the adjuvant setting for breast cancer: Reflexions about the risk of uterine carcinosarcoma]

Archive ouverte

Leung, F. | Terzibachian, J.-J. | Govyadovskiy, A. | Bourtembourg, A. | Maillet, R. | Riethmuller, D.

Edité par CCSD ; Elsevier Masson -

International audience. A descriptive analysis of available data on reported cases of uterine carcinosarcomas associated with tamoxifen therapy is undertaken. The role of aromatase inhibitors as alternative to tamoxifen therapy in the adjuvant setting of breast cancer is discussed. The eventual implications of the presumed association of uterine carcinosarcoma and tamoxifen therapy on the choice of the therapeutic agent in the adjuvant setting of hormone-sensitive breast cancer are discussed.

Consulter en ligne

Suggestions

Du même auteur

[Uterine carcinosarcomas associated with tamoxifen therapy. Report of two cases and review of the literature]

Archive ouverte | Leung, F. | CCSD

International audience. Carcinosarcomas are rare uterine cancers and carry poor prognosis. Although these tumours usually arise de novo, some cases developed under tamoxifen therapy have been reported. We report two...

[Radiation-induced breast angiosarcoma following breast-conserving therapy. Report of two cases]

Archive ouverte | Leung, F. | CCSD

International audience. Breast angiosarcoma is a rare but serious complication of radiotherapy. We report two cases of radiation-induced breast angiosarcoma in two patients having benefited from breast conserving su...

[Pure rhabdomyosarcoma of the uterine corpus: an exceptional tumor in postmenopausal women. Report on two cases]

Archive ouverte | Leung, F. | CCSD

International audience. Rhabdomyosarcoma (RMS) of the uterine corpus is rare in adult females. This tumor can be encountered in two distinct histopathological contexts: usually as a component of a malignant mixed mu...

Chargement des enrichissements...